Shanghai Henlius Biotech to join Hang Seng Composite Index from Sept. 7

PUBT · 2d ago
Shanghai Henlius Biotech to join Hang Seng Composite Index from Sept. 7
  • Shanghai Henlius Biotech will be added to the Hang Seng Composite Index, effective Sept. 7, 2026.
  • Change follows Hang Seng Indexes’ quarterly review for the period ended June 30, 2026, announced Aug. 21, 2026.
  • Inclusion is expected to make its H shares eligible for Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect.
  • Move is expected to broaden the shareholder base, lifting trading liquidity.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Henlius Biotech Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260821-12294618), on August 21, 2026, and is solely responsible for the information contained therein.